8 November 2024 | European Parliament, Strasbourg, France

The aim of this european meeting is to discuss the ongoing implementation and to forecast systemic consequences of the HTA Regulation (EU) 2021/2282, which will come into force on January 2025.

It will bring together in situ, leading figures from European and national HTA bodies as well as socio-economic players including European patients, physicians and entrepreneurs organizations, for direct, convivial, fruitful interactions.

Attendees are advanced students and academic researchers, national regulators, public & private decision makers operating in the fields of HTA and public governance, pharmaceutical law and regulatory affairs, market access.

This meeting is a pilot – the first of a series focusing on our Nations and Union transformations and future performance facing existential challenges … and opportunities ?

Download the full program here.